Solid growth in Algol Group’s net sales and earnings in 2022
The Algol Group’s business continued to develop favourably in 2022. Consolidated net sales increased by 29 percent to EUR 233 million, while operating profit improved to EUR 11.7 million. Nearly all Group companies improved their results compared to 2021 and also surpassed their budgeted target.
The growth and improvement in earnings were due to strong demand and especially higher raw material prices. The discontinuation of business operations in Russia, however, had a somewhat negative impact on earnings.
|Net sales, M€||233||181||151|
|Result after taxes||7.8||5.5||-0.2|
|Net debt, M€||Net debt free||4.4||7.8|
|Number of personnel on av.||476||463||477|
Outlook for the current year stable for the time being
The trend for the year 2023 is difficult to predict. The economic outlook in general is uncertain. For Algol, however, the situation appears stable. Algol Group companies operate in many different sectors and regions, which provides stability also in times of uncertainty.
The key figures for the current year are estimated to remain at a slightly lower level than the previous year. According to our assessment, however, the performance corresponds to our longer-term targets and expectations regarding moderate growth, continuous improvement in our results and strengthening our balance sheet.
THis is us
Algol is a Finnish family-owned business and a multi-branch company, which has been active in international trade since 1894. The Group comprises Algol Chemicals, Algol Diagnostics, Algol Technics, Algol Trehab, Histolab Products and Suomen Unipol.Read more
The basis of our operations
Trading involves responsibility for customers, suppliers, employees and society as a whole. We believe that international trade promotes global understanding, peaceful coexistence and stability.Read more
The Group comprises six business units: Algol Chemicals, Algol Diagnostics, Algol Technics, Algol Trehab, Histolab Products and Suomen Unipol.Read more
The Algol Group's business developed favourably during 2021. Consolidated net sales increased to EUR 181 million, while operating profit improved to EUR 6.7 million.Read more